Baylor College of Medicine

S1815: Gemcitabine and Cisplatin in Treating Patients With Newly Diagnosed Advanced Biliary Tract Cancers (H-45460)

Description

Content

This phase III trial studies how well gemcitabine hydrochloride and cisplatin given with or without nab-paclitaxel work in treating patients with newly diagnosed biliary tract cancers that have spread to other places in the body. Drugs used in chemotherapy, such as gemcitabine hydrochloride, cisplatin, and nab-paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. It is not known if giving gemcitabine hydrochloride and cisplatin with or without nab-paclitaxel may work better at treating biliary tract cancers.

See more information.

Contact

Dr. Benjamin Musher

Phone 1: 713–798–2878

IRB: H-45460

Status:

Active

Created:

Back to topback-to-top